Identification of Progressive Islet Biomarkers for Type 2 Diabetes by Integrated Transcriptomics and Mendelian Randomization: Alterations Spanning the Normal Glucose Tolerance-Impaired Glucose Tolerance-Type 2 Diabetes Continuum.

Aisikaer N, Liu Z, Cai S

Open source

DOI
10.3390/biomedicines14081850
Published
2026 Aug 18
Container
Biomedicines
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/biomedicines14081850,
  title = {Identification of Progressive Islet Biomarkers for Type 2 Diabetes by Integrated Transcriptomics and Mendelian Randomization: Alterations Spanning the Normal Glucose Tolerance-Impaired Glucose Tolerance-Type 2 Diabetes Continuum.},
  author = {Aisikaer N and Liu Z and Cai S},
  year = {2026},
  journal = {Biomedicines},
  doi = {10.3390/biomedicines14081850},
  url = {https://doi.org/10.3390/biomedicines14081850}
}

RIS

TY  - JOUR
TI  - Identification of Progressive Islet Biomarkers for Type 2 Diabetes by Integrated Transcriptomics and Mendelian Randomization: Alterations Spanning the Normal Glucose Tolerance-Impaired Glucose Tolerance-Type 2 Diabetes Continuum.
AU  - Aisikaer N
AU  - Liu Z
AU  - Cai S
PY  - 2026
JO  - Biomedicines
DO  - 10.3390/biomedicines14081850
UR  - https://doi.org/10.3390/biomedicines14081850
ER  - 

APA

N, A., Z, L., & S, C. (2026). Identification of Progressive Islet Biomarkers for Type 2 Diabetes by Integrated Transcriptomics and Mendelian Randomization: Alterations Spanning the Normal Glucose Tolerance-Impaired Glucose Tolerance-Type 2 Diabetes Continuum.. Biomedicines. https://doi.org/10.3390/biomedicines14081850

Source records